Results 21 to 30 of about 802,297 (310)

Inability to contact opioid agonist therapy prescribers during the COVID-19 pandemic in a Canadian setting: a cross-sectional analysis among people on opioid agonist therapy

Addiction Science & Clinical Practice, 2022
Background The COVID-19 pandemic and consequent public health response may have undermined key responses to the protracted drug poisoning crisis, including reduced access to opioid agonist therapy (OAT) among people with opioid use disorder.
Soroush Moallef, Kora DeBeck, Nadia Fairbairn, Zishan Cui, Rupinder Brar, Dean Wilson, Cheyenne Johnson, M.-J. Milloy, Kanna Hayashi   +8 more
doaj   +1 more source

Harm reduction calls to action from young people who use drugs on the streets of Vancouver and Lisbon

Harm Reduction Journal, 2022
Vancouver, Canada, and Lisbon, Portugal, are both celebrated for their world-leading harm reduction policies and programs and regarded as models for other cities contending with the effects of increasing levels of drug use in the context of growing urban
Joana Canêdo, Kali-olt Sedgemore, Kelly Ebbert, Haleigh Anderson, Rainbow Dykeman, Katey Kincaid, Claudia Dias, Diana Silva, Youth Health Advisory Council, Reith Charlesworth, Rod Knight, Danya Fast   +11 more
doaj   +1 more source

Housing-based syringe services programs to improve access to safer injecting equipment for people who inject drugs in Vancouver, Canada: a spatially oriented qualitative study

Harm Reduction Journal, 2023
Background Housing environments shape injection drug-related risks and harms and thus represent a critical implementation setting for syringe services programs (SSPs).
Koharu Loulou Chayama, Cara Ng, Taylor Fleming, Will Small, Kimberly L. Sue, Ryan McNeil   +5 more
doaj   +1 more source

Person-Environment Fit, Substance Use Attitudes, and Early Adolescent Substance Use

, 2019
BACKGROUND: Adolescent substance use is a national health concern. While the literature is clear on the prevalence of substance use during the adolescent developmental period, a dearth of literature is available on the developmental contexts ...
Al-Uqdah, Shareefah, Arsenault, Chelsea, Fisher, Sycarah, Stevens-Watkins, Danelle, Barnes-Najor, Jessica, Zapolski, Tamika   +5 more
core   +1 more source

High-intensity cannabis use and hospitalization: a prospective cohort study of street-involved youth in Vancouver, Canada

Harm Reduction Journal, 2021
Background There is concern that cannabis use negatively affects vulnerable groups such as youth; however, the relationship between cannabis use and health care utilization has not been well characterized in this population.
Hudson Reddon, M.-J. Milloy, Evan Wood, Ekaterina Nosova, Thomas Kerr, Kora DeBeck   +5 more
doaj   +1 more source

Problematic substance use or problematic substance use policies? [PDF]

Health Promotion and Chronic Disease Prevention in Canada, 2020
This special issue on substance use issues comes at a critical time for Canadian health policy makers and researchers. Most attention is currently focussed on the opioid crisis and the potential impacts of cannabis legalization. However, our most widely used and harmful substances continue to be alcohol and nicotine.
Stockwell, Tim, Benoit, Cecilia, Card, Kiffer, Sherk, Adam   +3 more
openaire   +3 more sources

European Standard Clinical Practice Guideline and EXPeRT Recommendations for the Diagnosis and Management of Gastroenteropancreatic Neuroendocrine Neoplasms in Children and Adolescents

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Pediatric gastroenteropancreatic neuroendocrine neoplasms (GEP‐NENs) are extremely rare and clinically heterogeneous. Management has largely been extrapolated from adult practice. This European Standard Clinical Practice Guideline (ESCP), developed by the EXPeRT network in collaboration with adult NEN experts, provides (adult) evidence ...
Michaela Kuhlen, Calogero Virgone, Antje Redlich, Michael Abele, Ricardo Lopez‐Almaraz, Tal Ben‐Ami, Ewa Bien, Gianni Bisogno, Maja Mazic Cesen, Andrea Ferrari, Malgorzata A. Krawczyk, Yves Reguerre, Dominik T. Schneider, Ines B. Brecht, Charlotte Rigaud, Bilgehan Yalcin, Rainer Claus, Christian Vokuhl, Constantin Lapa, Jörg Fuchs, Segolene Hescot, Thomas Walter, Julien Hadoux, Daniel Orbach   +23 more
wiley   +1 more source

Use of withdrawal management services among people who use illicit drugs in Vancouver, Canada

Substance Abuse Treatment, Prevention, and Policy, 2018
Background For many individuals with substance use disorders, the entry point for addiction treatment can be through withdrawal management (e.g. detoxification) services.
Sharon Vipler, Kanna Hayashi, M.-J. Milloy, Evan Wood, Ekaterina Nosova, Thomas Kerr, Lianping Ti   +6 more
doaj   +1 more source

Injecting drugs alone during an overdose crisis in Vancouver, Canada

Harm Reduction Journal, 2022
Background Settings throughout Canada and the USA continue to experience crises of overdose death due to the toxic unregulated drug supply. Injecting drugs alone limits the potential for intervention and has accounted for a significant proportion of ...
Alexa Norton, Kanna Hayashi, Cheyenne Johnson, JinCheol Choi, M-J Milloy, Thomas Kerr   +5 more
doaj   +1 more source

Clinical and Biological Features of Response in Resistant Neuroblastoma to 131I‐Metaiodobenzylguanidine Radiotherapy in the Anti‐GD2 Immunotherapy Era

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background 131I‐metaiodobenzylguanidine (131I‐MIBG) radiotherapy is a key treatment for relapsed and refractory (R/R) neuroblastoma (NB). Patients with R/R disease treated in the modern era are increasingly exposed to anti‐GD2 immunotherapy, which exerts selective pressure and may modify both tumor cell state and microenvironment.
Benjamin J. Lerman, Katherine K. Matthay, Fabienne Hollinger, Catriona Black, Ann A. Lazar, Miguel Pampaloni, Steven G. DuBois, Kieuhoa T. Vo   +7 more
wiley   +1 more source